Remember the torture memos? The boat strike memos may be worse. Ford workers told their CEO ‘none of the young people want to work here.’ So Jim Farley took a page out of the founder’s playbook Drone ...
Required minimum distributions (RMD) are mandatory withdrawals seniors must take from their retirement accounts starting at age 73. RMDs are not a set dollar amount. Rather, they're a sliver of your ...
Attention! Another new term has entered the TikTok lexicon, and you’re about to see it everywhere. If you’ve spent any time on the app within the past week, you might have noticed people talking about ...
A US Navy Global Autonomous Reconnaissance Craft (GARC) maneuvers in the Atlantic Ocean during UNITAS 2025 on Sept. 23, 2025. US Navy photo ARLINGTON, Va. — A new office consolidating the development ...
Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...
HEC Infra Projects Limited, a leading EPC company in India, has secured three significant contracts designed to expand its operations in urban water distribution and energy infrastructure. With a ...
Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.
Treatment with glucagon-like peptide 1 receptor agonists (GLP-1 RAs) for weight loss or diabetes management doesn ’t raise the risk for adverse psychiatric events and improves quality of life (QOL) in ...
Ras Baraka, the mayor of Newark and a candidate for New Jersey governor, appeared in federal court on Thursday, nearly a week after he was charged with trespassing. By Luis Ferré-Sadurní and Mark ...
Newark, New Jersey Mayor Ras Baraka was briefly arrested at an ICE detention center. The arrest occurred during an unannounced inspection by members of New Jersey's congressional delegation. Baraka, a ...
KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...